Nanoengineered on-demand drug delivery system improves efficacy of pharmacotherapy for epilepsy
Open Access
- 14 January 2022
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (2) , eabm3381
Abstract
Electroresponsive and synergistic brain-targeting nanoparticles improve efficacy of pharmacotherapy for epilepsy.Keywords
This publication has 40 references indexed in Scilit:
- Nanoparticles of 2-deoxy-d-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatmentBiomaterials, 2014
- New avenues for anti-epileptic drug discovery and developmentNature Reviews Drug Discovery, 2013
- On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsyNature Communications, 2013
- Adverse effects of antiepileptic drugsThe Lancet Neurology, 2012
- Minimally invasive molecular delivery into the brain using optical modulation of vascular permeabilityProceedings of the National Academy of Sciences, 2011
- The neurobiology of cognitive disorders in temporal lobe epilepsyNature Reviews Neurology, 2011
- PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumorsBiomaterials, 2011
- Adverse effects of antiepileptic drugs: a brief overview of important issuesExpert Review of Neurotherapeutics, 2010
- A revised Racine's scale for PTZ-induced seizures in ratsPhysiology & Behavior, 2009
- In Vivo Evidence for P‐Glycoprotein–Mediated Transport of Phenytoin at the Blood–Brain Barrier of RatsEpilepsia, 2001